Logo Logo

Publications by Valent, P.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 19.

Journal article

Kaivers, J.; Lauseker, Michael; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Latagliata, R.; Oliva, E. N.; Xicoy, B.; Götze, K.; Ganster, C.; Haase, D.; Bug, G.; Kündgen, A.; Gattermann, N.; Haas, R.; Germing, U. (2018): The IPSS-R has prognostic impact in untreated patients with MDS del(5q). In: Leukemia Research, Vol. 72: pp. 27-33

Peter, B.; Bibi, S.; Eisenwort, G.; Wingelhofer, B.; Berger, D.; Stefanzl, G.; Blatt, K.; Herrmann, H.; Hadzijusufovic, E.; Hoermann, G.; Hoffmann, T.; Schwaab, J.; Jawhar, M.; Willmann, M.; Sperr, W. R.; Zuber, J.; Sotlar, K.; Horny, H-P; Moriggl, R.; Reiter, A.; Arock, M.; Valent, P. (2018): Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. In: Leukemia, Vol. 32, No. 4: pp. 1016-1022

Valent, P.; Akin, C.; Hartmann, K.; George, T. I.; Sotlar, K.; Peter, B.; Gleixner, K. V.; Blatt, K.; Sperr, W. R.; Manley, P. W.; Hermine, O.; Kluin-Nelemans, H. C.; Arock, M.; Horny, H.-P.; Reiter, A.; Gotlib, J. (2017): Midostaurin: a magic bullet that blocks mast cell expansion and activation. In: Annals of Oncology, Vol. 28, No. 10: pp. 2367-2376

Gorska, A.; Gruchala-Niedoszytko, M.; Niedoszytko, M.; Rabenhorst, A.; Sperr, W.; Elberink, Oude J.; Lange, M.; Gleixner, K.; Brazzelli, V; Fontana, E.; Vos, B.; Reiter, A.; Schwaab, J.; Zanotti, R.; Bonadonna, P.; Triggiani, M.; Gotlib, J.; Doubek, M.; Jakob, T.; Fuchs, D.; Sabato, V; Zink, A.; Bretterklieber, A.; Jäkel, N.; Sotlar, K.; Horny, H.; Fortina, Belloni A.; Merante, S.; Kluin-Nelemans, H.; Valent, P.; Hartmann, K. (2017): The body mass index is an indicator of advanced systemic mastocytosis: preliminary results from a registry project of the European Competence Network on Mastocytosis (ECNM) registry. In: Allergy, Vol. 72: pp. 126-127

Niedoszytko, M.; Gorska, A.; Nedoszytko, B.; Rabenhorst, A.; Sperr, W.; Elberink, Oude J.; Lange, M.; Gleixner, K.; Brazzelli, V; Fontana, E.; Vos, B.; Reiter, A.; Schwaab, J.; Zanotti, R.; Bonadonna, P.; Triggiani, M.; Gotlib, J.; Doubek, M.; Jakob, T.; Fuchs, D.; Sabato, V; Zink, A.; Bretterklieber, A.; Jäkel, N.; Sotlar, K.; Horny, H.; Fortina, Belloni A.; Merante, S.; Kluin-Nelemans, H.; Valent, P.; Hartmann, K. (2017): Impact of allergic disorders and anaphylaxis in mastocytosis: Preliminary data from a study of the European Competence Network on Mastocytosis (ECNM) registry. In: Allergy, Vol. 72: pp. 212-213

Valent, P.; Sotlar, K.; Blatt, K.; Hartmann, K.; Reiter, A.; Sadovnik, I.; Sperr, W. R.; Bettelheim, P.; Akin, C.; Bauer, K.; George, T. I.; Hadzijusufovic, E.; Wolf, D.; Gotlib, J.; Mahon, F.-X.; Metcalfe, D. D.; Horny, H.-P.; Arock, M. (2017): Proposed diagnostic criteria and classification of basophilic leukemias and related disorders. In: Leukemia, Vol. 31, No. 4: pp. 788-797

Rabenhorst, A.; Sperr, W.; Elberink, J. Oude; Lange, M.; Gleixner, K.; Brazzelli, V.; Fontana, E.; Vos, B.; Gorska, A.; Reiter, A.; Schwaab, J.; Zanotti, R.; Bonadonna, P.; Triggiani, M.; Gotlib, J.; Doubek, M.; Jakob, T.; Kilbertus, A.; Sabato, V.; Zink, A.; Bretterklieber, A.; Jäkel, N.; Sotlar, K.; Horny, H.; Fortina, A. Belloni; Merante, S.; Niedoszytko, M.; Kluin-Nelemans, H.; Valent, P.; Hartmann, K. (2017): Age at disease onset has a major impact on clinical characteristics and course of mastocytosis. In: Experimental Dermatology, Vol. 26, No. 3, E6-E6

Reiter, A.; Kluin-Nelemans, H. C.; George, T.; Akin, C.; DeAngelo, D. J.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Schwaab, J.; Jawhar, M.; Sternberg, D.; Berkowitz, N.; Niolat, J.; Labed, A. Huntsman; Hartmann, K.; Horny, H.-P.; Valent, P.; Gotlib, J. (2017): Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls. In: Haematologica, Vol. 102: pp. 321-322

Jawhar, M.; Schwaab, J.; Schnittger, S.; Meggendorfer, M.; Pfirrmann, Markus; Sotlar, K.; Horny, H. P.; Metzgeroth, G.; Kluger, S.; Naumann, N.; Haferlach, C.; Haferlach, T.; Valent, P.; Hofmann, W. K.; Fabarius, A.; Cross, N. C.; Reiter, A. (2016): Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. In: Leukemia, Vol. 30, No. 1: pp. 136-143

Jawhar, M.; Schwaab, J.; Hausmann, D.; Clemens, J.; Naumann, N.; Henzler, T.; Horny, H.-P.; Sotlar, K.; Schoenberg, S. O.; Cross, N. C. P.; Fabarius, A.; Hofmann, W.-K.; Valent, P.; Metzgeroth, G.; Reiter, A. (2016): Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis. In: Leukemia, Vol. 30, No. 12: pp. 2342-2350

Jawhar, M.; Schwaab, J.; Hausmann, D.; Clemens, J.; Naumann, N.; Henzler, T.; Horny, H. P.; Sotlar, K.; Schoenberg, S. O.; Cross, N. C.; Fabarius, A.; Hofmann, W. K.; Valent, P.; Metzgeroth, G.; Reiter, A. (2016): Splenomegaly and elevated alkaline phosphatase are strong and independent adverse prognostic markers in patients with systemic mastocytosis. In: Haematologica, Vol. 101: p. 559

Naumann, N.; Jawhar, M.; Schwaab, J.; Metzgeroth, G.; Khaled, N.; Horny, H.-P.; Sotlar, K.; Valent, P.; Haferlach, C.; Göhring, G.; Schlegelberger, B.; Meggendorfer, M.; Cross, N. C. P.; Hofmann, W. K.; Reiter, A.; Fabarius, A. (2016): Incidence and prognostic impact of cytogenetic aberrations in systemic mastocytosis. In: Oncology Research and Treatment, Vol. 39: p. 25

Jawhar, M.; Schwaab, J.; Hausmann, D.; Clemens, J.; Naumann, N.; Henzler, T.; Horny, H.-P.; Sotlar, K.; Schoenberg, S. O.; Cross, N. C. P.; Fabarius, A.; Hofmann, W.-K.; Valent, P.; Metzgeroth, G.; Reiter, A. (2016): Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis. In: Oncology Research and Treatment, Vol. 39: p. 232

Schwaab, J.; Schnittger, S.; Sotlar, K.; Walz, C.; Fabarius, A.; Pfirrmann, Markus; Kohlmann, A.; Grossmann, V.; Meggendorfer, M.; Horny, H. P.; Valent, P.; Jawhar, M.; Teichmann, M.; Metzgeroth, G.; Erben, P.; Ernst, T.; Hochhaus, A.; Haferlach, T.; Hofmann, W. K.; Cross, N. C.; Reiter, A. (2013): Comprehensive mutational profiling in advanced systemic mastocytosis. In: Blood, Vol. 122, No. 14: pp. 2460-2466

Horny, H. -P.; Sotlar, K.; Valent, P. (2012): Evaluation of Mast Cell Activation Syndromes: Impact of Pathology and Immunohistology. In: International Archives of Allergy and Immunology, No. 1: pp. 1-5 [PDF, 106kB]

Germing, U.; Lauseker, Michael; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Fenaux, P.; Kelaidi, C.; Pfeilstöcker, M.; Nosslinger, T.; Sekeres, M.; Maciejewski, J.; Haase, D.; Schanz, J.; Seymour, J.; Kenealy, M.; Weide, R.; Lubbert, M.; Platzbecker, U.; Valent, P.; Gotze, K.; Stauder, R.; Blum, S.; Kreuzer, K. A.; Schlenk, R.; Ganser, A.; Hofmann, W. K.; Aul, C.; Krieger, O.; Kundgen, A.; Haas, R.; Hasford, Joerg; Giagounidis, A. (2012): Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study. In: Leukemia, Vol. 26, No. 6: pp. 1286-1292

Horny, H. -P.; Sotlar, K.; Valent, P. (2010): Differential Diagnoses of Systemic Mastocytosis in Routinely Processed Bone Marrow Biopsy Specimens: A Review. In: Pathobiology, No. 4: pp. 169-180 [PDF, 1MB]

Steidl, C.; Schanz, J.; Pfeilstöcker, M.; Nösslinger, T.; Hildebrandt, B.; Kuendgen, A.; Lübbert, M.; Giagounidis, A.; Aul, C.; Trümper, L.; Krieger, O.; Stauder, R.; Müller, Thomas H.; Wiamzal, F.; Valent, P.; Fonatsch, C.; Germing, U.; Hasse, D. (2007): Growing evidence for an underestimation of poor-risk cytogenetics in the international prognostic scoring system in myelodysplastic syndromes. In: Clinical Leukemia, Vol. 1, No. 6: pp. 353-356

Germing, U.; Hildebrandt, B.; Pfeilstöcker, M.; Nosslinger, T.; Valent, P.; Fonatsch, C.; Lubbert, M.; Haase, D.; Steidl, C.; Krieger, O.; Stauder, R.; Giagounidis, A. A.; Strupp, C.; Kundgen, A.; Mueller, T.; Haas, R.; Gattermann, N.; Aul, C. (2005): Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). In: Leukemia, Vol. 19, No. 12: pp. 2223-2231

This list was generated on Sat Sep 21 18:07:43 2019 CEST.